Publication:
The utility of 68Ga-PSMA PET/CT in poorly differentiated metastatic prostate cancer

Simple item page
dc.contributor.coauthorUcar, Burcu
dc.contributor.coauthorSaglican, Yesim
dc.contributor.departmentSchool of Medicine
dc.contributor.facultymemberYes
dc.contributor.kuauthorDemirkol, Mehmet Onur
dc.contributor.kuauthorKiremit, Murat Can
dc.contributor.kuauthorAcar, Ömer
dc.contributor.schoolcollegeinstituteSCHOOL OF MEDICINE
dc.date.accessioned2024-11-09T23:59:47Z
dc.date.issued2017
dc.description.abstractWe aimed to emphasize how useful PSMA PET/CT findings can be while trying to restage prostate cancer after radical prostatectomy in the presence of low prostate-specific antigen values. A 64-year-old man with pT3b N1 M0 Gleason 7 adenocarcinoma of the prostate presented 5 years postoperatively with a palpable axillary mass, whereas his prostate-specific antigen was 0.08 ng/mL. Conventional imaging studies and histopathologic findings of the axillary mass biopsy revealed inconclusive results. 68Ga-PSMA PET/CT demonstrated PSMA-positive metastatic lesions, the largest one being located in the right axilla. This finding confirmed metastatic poorly differentiated prostate cancer, and androgen deprivation therapy was initiated.
dc.description.fulltextNo
dc.description.harvestedfromManual
dc.description.indexedbyWOS
dc.description.indexedbyScopus
dc.description.indexedbyPubMed
dc.description.openaccessNO
dc.description.peerreviewstatusN/A
dc.description.publisherscopeInternational
dc.description.readpublishN/A
dc.description.sponsoredbyTubitakEuN/A
dc.description.versionN/A
dc.identifier.doi10.1097/RLU.0000000000001617
dc.identifier.eissn1536-0229
dc.identifier.embargoN/A
dc.identifier.endpage405
dc.identifier.issn0363-9762
dc.identifier.issue5
dc.identifier.pubmed28319496
dc.identifier.quartileQ1
dc.identifier.scopus2-s2.0-85015658830
dc.identifier.startpage403
dc.identifier.urihttps://doi.org/10.1097/RLU.0000000000001617
dc.identifier.urihttps://hdl.handle.net/20.500.14288/15688
dc.identifier.volume42
dc.identifier.wos000399411600039
dc.keywords68Ga
dc.keywordsProstate cancer
dc.keywordsProstate-specific membrane antigen
dc.language.isoeng
dc.publisherWolters Kluwer
dc.relation.affiliationKoç University
dc.relation.collectionKoç University Institutional Repository
dc.relation.ispartofClinical Nuclear Medicine
dc.relation.openaccessN/A
dc.rightsN/A
dc.subjectNuclear medicine
dc.subjectUrologic oncology
dc.subjectMedical imaging
dc.title The utility of 68Ga-PSMA PET/CT in poorly differentiated metastatic prostate cancer
dc.typeOther
dspace.entity.typePublication
local.contributor.kuauthorDemirkol, Mehmet Onur
local.contributor.kuauthorKiremit, Murat Can
local.contributor.kuauthorAcar, Ömer
relation.isGoalOfPublication022a3f53-b0ba-4d9e-8d2e-e884e82c579c
relation.isGoalOfPublication.latestForDiscovery022a3f53-b0ba-4d9e-8d2e-e884e82c579c
relation.isOrgUnitOfPublicationd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isOrgUnitOfPublication.latestForDiscoveryd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isParentOrgUnitOfPublication17f2dc8e-6e54-4fa8-b5e0-d6415123a93e
relation.isParentOrgUnitOfPublication.latestForDiscovery17f2dc8e-6e54-4fa8-b5e0-d6415123a93e

Files

Collections

Publications without Fulltext